The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis

OBJECTIVE: Immunological studies have demonstrated a plethora of beneficial effects of dimethyl fumarate (DMF) on various cell types. However, the cellular and molecular targets are incompletely understood and response markers are scarce. Here, we focus on the relation between nuclear factor (erythr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Clin Transl Neurol
Autores principales: Hammer, Anna, Waschbisch, Anne, Kuhbandner, Kristina, Bayas, Antonios, Lee, De‐Hyung, Duscha, Alexander, Haghikia, Aiden, Gold, Ralf, Linker, Ralf A.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5989754/
https://ncbi.nlm.nih.gov/pubmed/29928650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.553
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares